Current Opinion in Hematology

About Current Opinion in Hematology

About Current Opinion in Hematology

Current Opinion in Hematology is a peer-reviewed scholarly journal published by Lippincott Williams and Wilkins (United States). It focuses on Q1. Publication coverage spans 1994-2026.

Key indicators: ISSN 1531-7048, 1065-6251; H-index 113.

Understanding This Journal's Metrics

Journal metrics help researchers assess fit, but they must be interpreted in context:

• H-index (113): Exceptionally high — 113 articles have each been cited at least 113 times. This indicates deep, sustained influence in the field.

Publishing in Current Opinion in Hematology

An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.

• Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
• Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.

Is This Journal Right for Your Paper?

• Audience match: Will the journal's readers cite and build on your findings?
• Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
• Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
• Open access needs: Check funder mandates and whether the journal offers compliant OA options.

Frequently Asked Questions

What is the ISSN of Current Opinion in Hematology?
1531-7048, 1065-6251.

Who publishes Current Opinion in Hematology?
Lippincott Williams and Wilkins.

What are Current Opinion in Hematology's metrics?
H-index 113.

Is Current Opinion in Hematology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.